ADC Therapeutics Files Registration Statement for Proposed Initial Public Offering
LAUSANNE, Switzerland, April 24, 2020 (GLOBE NEWSWIRE) -- ADC Therapeutics SA, a late clinical-stage oncology-focused biotechnology company pioneering the development and commercialization of highly potent and targeted antibody drug conjugates for patients …